Please ensure Javascript is enabled for purposes of website accessibility

Zeltiq Aesthetics Earnings: CoolSculpting Heats Up

By Rick Munarriz - Oct 30, 2015 at 10:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company behind the CoolScuplting fat cell freezing platform delivers another quarter of growth.

Source: Zetliq Aesthetics. 

Zeltiq Aesthetics (ZLTQ) continues to come through with strong sales growth, robust profitability, and a welcome habit of jacking up its guidance every three months.

The company behind the CoolSculpting machines that freeze fat cells in a painless and non-invasive procedure posted another strong quarter earlier this week. Revenue clocked in at $61.2 million. That's a sequential dip from the record $64.4 million that it recorded during the second quarter, but there is seasonality to the model. Zeltiq's top line also took a sequential step down in 2012 and 2014. 

Zeltiq shipped 337 new CoolSculpting machines during the period, bringing its installed base to 4,247 fat cell-freezing contraptions. That was good for nearly half -- or $29.3 million -- of Zeltiq's total revenue, but the real growth these days has been coming from consumable revenue that clocked in at $31.9 million. This is the second quarter in a row that the higher-margin revenue associated with the actual use of the machines tops the initial hardware sales. In short, they're not collecting dust after being purchased by physicians, dermatologists, and other weight-loss specialists. 

Revenue growth continues to decelerate. The seemingly impressive 36% year-over-year surge on the top line is actually the weakest increase since the second quarter of 2013, according to S&P Capital IQ data. However, the shift to the chunkier margins in its consumable revenue -- and revenue cycles have soared 55% over the past year -- have resulted in expanding gross profit margins.

It's not trickling all the way down to the bottom line. Zeltiq's investments in super-sizing its sales team and marketing the platform have eaten away at overall profitability. It's hard to make earnings grow when a 36% year-over-year uptick in revenue is more than offset by a 54% spike in operating expenses. However, after a couple years of red ink Zeltiq has come through with a profit in five of the past six quarters. Zeltiq's earnings of $0.05 a share were a step down from its profit of $0.12 a share a year earlier, but the market was braced for a quarterly deficit. That didn't happen.

Zeltiq continues to find new ways to use its machine. It was initially approved by regulators to treat flanks or love handles. It then expanded to thighs and stomachs. It continues to make headway on CoolMini, a tweak that would treat smaller areas including double chins and the CoolSmooth Pro applicator that will shorten procedure times by using cooler temperatures. Zeltiq remains on track to go with colder temperatures next year, and that could be a game changer since shaving the procedure time by nearly half would translate into more treatments per machine. 

Improving prospects find Zeltiq once again juicing up some aspects of its outlook for the entire year. It now sees $252 million in revenue for 2015. That was a range of $245 million to $247 million three months earlier, $235 million to $238 million three months before that, and $230 million to $235 million when it initiated its guidance back in January. It also boosted its outlook for operating margin and adjusted EBITDA slightly higher. 

Zeltiq has quietly emerged as a market darling. The stock's been a 10-bagger since bottoming out in early 2013. CoolSculpting machines may prove slimming, but the stock itself is gladly taking on weight.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

ZELTIQ Aesthetics, Inc. Stock Quote
ZELTIQ Aesthetics, Inc.
ZLTQ

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
311%
 
S&P 500 Returns
110%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.